Cosmos Health (COSM) FCF Margin (2014 - 2026)
Cosmos Health's (COSM) quarterly FCF Margin came in at 6.02% in Q1 2026, down 457.0% YoY from 1.69% in Q1 2025, and down 157.32% on a QoQ basis from 10.5% in Q4 2025.
Cosmos Health (COSM) FCF Margin (2014 - 2026) Analysis & Trends
Cosmos Health (COSM) has 12 years of FCF Margin data on file, last reported at 6.02% in Q1 2026.
- Quarterly FCF Margin fell 457.0% year-over-year to 6.02% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 158.62% (down 14958.0% YoY) and the FY2025 annual result came in at 500.19%, down 48525.0% from the prior year.
- FCF Margin fell to 6.02% in Q1 2026, from 10.5% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 10.5% in Q4 2025 to a low of 85.93% in Q4 2022.
- A 5-year average of 19.76% and a median of 12.77% in 2022 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin slumped 7599 bps — and 2023, when it surged 9164 bps.
- Tracing COSM's FCF Margin over 5 years: stood at 85.93% in 2022, then surged by 107 bps to 5.71% in 2023, then tumbled by 581 bps to 27.46% in 2024, then surged by 138 bps to 10.5% in 2025, then plunged by 157 bps to 6.02% in 2026.
- The last three FCF Margin figures came in at 6.02% (Q1 2026), 10.5% (Q4 2025), and 14.42% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 100.02 Bn | 94.85 Bn | 3.69 Bn | -0.32% |
| 2 | Cencora | 60.88 Bn | 58.06 Bn | 3.61 Bn | 2.86% |
| 3 | Cardinal Health | 54.14 Bn | 49.29 Bn | 2.56 Bn | 2.24% |
| 4 | Henry Schein | 10.05 Bn | 9.90 Bn | 1.10 Bn | 6.13% |
| 5 | Akso Health | 737.16 Mn | 736.96 Mn | - | - |
| 6 | Edap Tms | 159.12 Mn | 137.58 Mn | 7.34 Mn | -29.43% |
| 7 | Accendra Health | 100.85 Mn | 93.20 Mn | 263.41 Mn | -7.05% |
| 8 | 111 | 32.10 Mn | -26.65 Mn | 18.18 Mn | -3.87% |
| 9 | Cosmos Health | 12.73 Mn | 10.29 Mn | 1.51 Mn | -9.39% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 24.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.02% |
| Dec 31, 2025 | 10.50% |
| Sep 30, 2025 | -14.42% |
| Jun 30, 2025 | -8.36% |
| Mar 31, 2025 | -1.45% |
| Dec 31, 2024 | -27.46% |
| Sep 30, 2024 | 4.12% |
| Jun 30, 2024 | -9.43% |
| Mar 31, 2024 | -23.96% |
| Dec 31, 2023 | 5.71% |
| Sep 30, 2023 | -35.40% |
| Jun 30, 2023 | -56.16% |
| Mar 31, 2023 | -51.58% |
| Dec 31, 2022 | -85.93% |
| Sep 30, 2022 | -12.77% |
| Jun 30, 2022 | -5.40% |
| Mar 31, 2022 | -17.91% |
| Dec 31, 2021 | -9.94% |
| Sep 30, 2021 | -26.03% |
| Jun 30, 2021 | -12.55% |